&#xa0;
defaultWritten evidence submitted by default the European Herbal and Traditional Medicine Practitioners Association (EHTPA) (AMRdefault0008default)defaultThe EHTPA is an umbrella body which represents professional associations of herbal/traditional medicine practitioners offering variously western herbal medicine, Chinese herbal medicine, 
defaultAyurveda
default and traditional Tibetan medicine. The EHTPA is dedicated to the development of herbal/traditional medicine, preserving and enhancing the legal basis of practice across EU Members States and promoting best practice throughout the traditions. 
defaultDeclaration of interests
defaultThe EHTPA is dedicated to the appropriate use of herbal medicine, the development of herbal/traditional medicine, promoting best practice across the various herbal traditions. The EHTPA is a not-for-profit association.
defaultHerbs to combat the threat of microbial resistance to antibiotics
default&#xa0;defaultExecutive Summary
defaultIn light of growing concerns relating to microbial resistance to antibiotics increasing attention is being given to the role that herbal medicines may play as autonomous anti-bacterial agents or as adjuvant treatments used to potentiate conventional drugs. This paper selectively reviews the evidence for herbal medicine as a valuable resource to combat bacterial resistance to antibiotics and suggests that further research is warranted.  
default&#xa0;defaultTable 1: Herbs to help combat growing antibiotic resistancedefaultStudy DesigndefaultPublication DetailsdefaultMain FindingsdefaultPossible MechanismsdefaultStrength of EvidencedefaultAn evidence-based systematic review of 
defaultumckaloabo
default (
defaultPelargonium 
defaultsidoides
default) by the US Natural Standard Research Collaboration.
defaultUlbricht C
default et al. (2010) 
defaultJournal of Dietary Supplements
default ;7(3):283-302.
defaultThis comprehensive systematic review concluded that there was strong scientific evidence (Grade A) - including 4 good quality RCTs involving 933 participants - to support the use of pelargonium for acute bronchitis and good scientific evidence (Grade B) for the its use in acute 
defaultpharyngitis
default and the common cold. No serious toxic effects have been observed in any trial relating to pelargonium.
defaultPelargonium has exhibited a marked antibacterial action against a wide range of pathogenic bacteria.
defaultHighdefaultEfficacy and safety of a combination herbal medicinal product containing nasturtium (
defaultTropaeoli
default 
defaultmajoris
default 
defaultherba
default)  and Horseradish (
defaultArmoracia
default 
defaultrusticana
default)
defaultfor the prophylactic treatment of patients with respiratory tract diseases: a 
defaultrandomised
default, prospective, double-blind, placebo-
defaultcontrolled phase III trial.
defaultFintelmann
default V
default et al. (2012). 
defaultCurrent Medical Research Opinion
default; 28(11):1799-807.
default351 participants were randomly allocated to either active treatment (Group 1), a lower dose of active herbs + placebo (Group 2), or just placebo (Group 3). The maximum duration of treatment was 84 days.
defaultIn the intention to treat (ITT) 
defaultpopulation excluding early infections (n = 344) the infection rates were 13.3% for Group 1, 18.4% for Group 2 and 25.6% for placebo Group 3. The statistical trend test showed significant results (p = 0.0171). The herbal combination appears to offer a prophylactic advantage which could help reduce antibiotic prescription.
defaultThese herbs contain several 
defaultisothiocyanates
default which have a marked in vitro broad spectrum anti-bacterial action.
defaultModeratedefaultA double blind randomised control trial where 107 participants were randomised to receive either 
defaultlicorice
default root (
defaultGlycyrrhiza
default 
defaultglabra
default ) - trade name 
defaultgutgard
default - or placebo for 60 days
defaultPuram
default et al. (2013) 
defaultEvidence-Based Complementary and Alternative Medicine
default; Article ID 263805.
defaultThe results showed that 56% (n=28) were 
defaultH.pylori
default negative compared to 4% (n=2) in the placebo group.  In other work by the same team, the herb extract reduced symptoms of dyspepsia and there were no adverse events reported.
defaultGlycyrrhiza
default 
defaultglabra
default showed antimicrobial activity in vitro and anti-adhesive properties against H-pylori.
defaultModeratedefaultA 
defaultrandomised
default, double-blind, placebo-controlled trial of a herbal medicinal product 
defaultAngocin
default Anti-
defaultInfekt
default N
default containing nasturtium (
defaultTropaeoli
default 
defaultmajoris
default 
defaultherba
default) and horseradish
default (
defaultArmoraciae
default 
defaultrusticana
default)
default for the prophylactic treatment of 
defaultpatients with chronically recurrent lower urinary tract infections (RUTIs).
default&#xa0;defaultAlbrecht U
default et al. (2007).  
defaultCurrent Medical Research Opinion
default;23(10):2415-22.
default&#xa0;
default129 patients with RUTIs were randomised to active herbal or placebo treatment for 90 days. The primary outcome was the number of laboratory confirmed urinary tract infections.
default The per protocol mean number of recurrent UTIs in the 
defaultstudy period was 0.43 versus 0.77 for the placebo group. This result is statistically significant (p = 0.035). A total of 36 patients in the test group and 37 patients in the placebo group reported adverse events. Two serious adverse events were reported in the placebo group and one serious adverse event in the treatment group (not associated with the study medication).
defaultThis herbal product appears to be effective and safe as a prophylaxis for RUTIs.
defaultMustard oils (including 
defaultisothiocyanates
default) found in these two herbs have been shown to have a broad spectrum antibacterial action.
defaultPreliminarydefault (This trial needs to be repeated by independent researchers using an intention to treat 
defaultanalysis.)
defaultA randomised control trial of a complex Chinese herbal medicine (San Ling 
defaultJie
default Du Tang) in the treatment of women with recurrent lower urinary tract infections (RUTIs)
defaultHuang MJ. (2007). 
defaultHubei J. of Traditional Chinese Medicine
default;29:38-9.
default300 women were randomised in a 2:1 ratio to the Chinese herbal remedy or an antibiotic. Treatment was administered for 7 days with a 6 month follow up. 
default79.5% of the herbal group reported no infection in the follow up period compared with 49% in the antibiotic group. This was statistically significant (p&lt;0.05).
defaultSeveral of the included herbs, such as tree peony bark (
defaultPaeonia
default 
defaultsuffroticosa
default),
default have been shown to have a broad spectrum antibacterial action.
defaultPreliminarydefault (Due to a lack of detail relating to the trial methodology.)
defaultA Cochrane systematic review of Chinese herbs for sore throat.
defaultHuang Y et al. (2012).  
defaultCochrane Database Systematic Review
default.
default 14;3:CD004877.
default12 studies involving 1954 participants were included in this systematic review. 6/12 studies were shown to be more effective than the control with 3 herbal remedies appearing more effective than antibiotics. The remaining 6 studies showed equivalent effectiveness to the controls.
defaultSeveral of the included herbs such as Japanese Honeysuckle (
defaultLonicera
default japonica)
default, have been shown to have a broad spectrum anti-bacterial action.
defaultPreliminarydefault (Due to the poor methodological quality of the included trials.)
defaultComparative study 
defaultof 
defaultNigella
default 
defaultsativa
default 
defaultand triple therapy in eradication of 
defaultHelicobacter pylori 
defaultin patients with non-ulcer dyspepsia.  88 adults with dyspeptic symptoms and positive 
defaultH.pylori
default test were randomised to four groups: receiving 
defaulti
default) triple therapy (TT) comprising of 
defaultclarithromycin
default, amoxicillin, 
defaultomeprazole
default [n= 23], ii) 1 g 
defaultNigella
default 
defaultsativa
default + 40 mg 
defaultomeprazole
default (OM) [n= 21], iii) 2 g NS + OM [n= 21] or iv) 3 g NS + OM [n= 23].  Main outcome was eradication of 
defaultH.pylori
default.
defaultSalem et al. (2010). 
defaultSaudi Journal of Gastroenterology
default. 16(3):207-14.
defaultH.pylori
default eradication was 82.6% in the antibiotic triple therapy group, 47.6 with 1g of 
defaultNigella
default 
defaultsativa
default,
default 66.7% with 2g and 47.8% with 3g 
defaultNigella
default 
defaultsativa
default.
default Eradication rates with 2 g 
defaultNigell
default 
defaultsativa
default and antibiotics were statistically similar.  
defaultNigella
default 
defaultsativa
default seeds possess clinically useful anti-
defaultH.pylori
default activity, comparable to antibiotic triple therapy. Further clinical studies combining 
defaultNigella
default 
defaultsativa
default with antibiotics are suggested by the authors.
defaultIn vitro study showed that 
defaultNigella
default 
defaultsativa
default inhibited growth in all strains of 
defaultH.pylori
default within 60 minutes of exposure.
defaultPreliminarydefault&#xa0;
defaultNovember 2013
default&#xa0;
default&#xa0;
default 
defaultGibbs, R. Evaluating the Biological Actions of Chinese Medicinal Herbs. 
defaultRegister of Chinese Herbal Medicine Journal
default 
default10
default, 31 – 38 (2013).
default 
defaultTeucher, B., Olivares, M. Cori, H. Enhancers of iron absorption: Ascorbic acid and other organic acids. 
defaultInternational journal for vitamin and nutrition research
default 
default74
default, 403–419 (2004).
default 
defaultBishayee
default A, 
defaultThoppil
default RJ, 
defaultWaghray
default A, Kruse JA, Novotny NA, 
defaultDarvesh
default AS. Dietary 
defaultphytochemicals
default in the chemoprevention and treatment of 
defaulthepatocellular
default carcinoma: in vivo evidence, molecular targets, and clinical relevance. 
defaultCurr
default Cancer Drug Targets.
default 2012 Nov 1;12(9):1191-232.
default 
defaultRicciardiello
default L, 
defaultBazzoli
default F, 
defaultFogliano
default V. 
defaultPhytochemicals
default and colorectal cancer prevention--myth or reality? 
defaultNat Rev 
defaultGastroenterol
default 
defaultHepatol
default.
default 2011
default Sep 6;8(10):592-6. 
default 
defaultFiebich
default BL, 
defaultKnörle
default R, 
defaultAppel
default K, 
defaultKammler
default T, Weiss G.  
defaultPharmacological studies in an herbal drug combination of St. John's 
defaultWort
default (
defaultHypericum
default 
defaultperforatum
default) and passion flower (
defaultPassiflora
default 
defaultincarnata
default): in vitro and in vivo evidence of synergy between 
defaultHypericum
default and 
defaultPassiflora
default in antidepressant pharmacological models.
default 
defaultFitoterapia
default.
default 2011 Apr;82
default(3):474-80. 
default 
defaultGertsch
default J. Botanical drugs, synergy, and network pharmacology: forth and back to intelligent mixtures.
default 
defaultPlanta
default Med
default. 2011 Jul;77(11):1086-98. 
defaultdoi
default: 10.1055/s-0030-1270904. 
defaultEpub
default 2011 Mar 16.
default 
defaultHemaiswarya
default S, 
defaultKruthiventi
default AK, 
defaultDoble
default M. Synergism between natural products and antibiotics against infectious diseases. 
defaultPhytomedicine
default. 2008 Aug;15(8):639-52.
default Wagner H, Ulrich-
defaultMerzenich
default G. Synergy research: approaching a new generation of 
defaultphytopharmaceuticals
default. 
defaultPhytomedicine
default. 2009 Mar;16(2-3):97-110. Review part 1.
default Ibid. 
default Chan BC, 
defaultIp
default M, Lau CB, 
defaultLui
default SL, 
defaultJolivalt
default C, 
defaultGanem-Elbaz
default C, 
defaultLitaudon
default M, Reiner NE, Gong H, See RH, Fung KP, Leung PC. Synergistic effects of 
defaultbaicalein
default with ciprofloxacin against 
defaultNorA
default over-expressed 
defaultmethicillin
default-resistant 
defaultStaphylococcus 
defaultaureus
default (MRSA) and inhibition of MRSA 
defaultpyruvate
default 
defaultkinase
default. 
defaultJ 
defaultEthnopharmacol
default. 2011 Sep  1;137(1):767-73.
default 
defaultKourtesi
default C, Ball AR, Huang Y, 
defaultJachak
default SM, Vera DMA, 
defaultKhondkar
default P, Gibbons S, Hamblin MR, 
defaultTegos
default GP. (2013). Drug Discovery and the Challenge of Clinical Implementation.  
defaultOpen Microbiology Journal
default.   7, ( S: 1M3 ) 34-52.
default  
defaultZuo
default GY, Zhang XY, Yang CX, Han J, Wang GC, 
defaultBian
default ZQ. (2012a). Evaluation of traditional Chinese medicinal plants for anti-MRSA activity with reference to the treatment record of infectious diseases.  
defaultMolecules
default.  17: 2955-2967.
default  
defaultKlančnik
default A, 
defaultMožina
default SS, Zhang Q. (2012). 
defaultAnti-Campylobacter
default activities and resistance mechanisms of natural 
defaultphenolic
default compounds in 
defaultCampylobacter
default.  
defaultPLoS
default One.  7(12).
default 
defaultKurinčič
default M, 
defaultKlančnik
default A, 
defaultSmole
default 
defaultMožina
default S (2012).  Effects of efflux pump inhibitors on erythromycin, ciprofloxacin, and tetracycline resistance in 
defaultCampylobacter 
defaultspp. isolates. 
defaultMicrobial Drug Resistance
default. 18(5):492-501.
default 
default 
defaultZuo
default GY, Li Y, Han J, Wang GC, Zhang YL, 
defaultBian
default ZQ. (2012). Antibacterial and synergy of 
defaultberberines
default with antibacterial agents against clinical multi-drug resistant Isolates of 
defaultmethicillin
default-resistant 
defaultStaphylococcus 
defaultaureus
default (MRSA). 
defaultMolecules.
default  17(9), 10322-10330.
default  
defaultChan BC, 
defaultIp
default M, Lau CB, 
defaultLui
default SL, 
defaultJolivalt
default C, 
defaultGanem-Elbaz
default C, 
defaultLitaudon
default M, Reiner NE, Gong H, See RH, Fung KP, Leung PC. (2011). Synergistic effects of 
defaultbaicalein
default with ciprofloxacin against 
defaultNorA
default over-expressed 
defaultmethicillin
default-resistant 
defaultStaphylococcus 
defaultaureus
default (MRSA) and inhibition of MRSA 
defaultpyruvate
default 
defaultkinase
default.  
defaultJournal of 
defaultEthnopharmacology
default.   1;137(1):767-73.
default 
defaultPonnusamy
default K, 
defaultRamasamy
default M, 
defaultSavarimuthu
default L, 
defaultPaulraj
default MG. (2010).  
defaultIndirubin
default potentiates ciprofloxacin activity in the 
defaultNorA
default efflux pump of 
defaultStaphylococcus 
defaultaureus
default.  
defaultScandinavian Journal of Infectious Diseases.
default  42, (6-7) :500-505.
default 
defaultZuo
default GY, 
defaultWanga
default GC, Zhao YB, 
defaultXua
default GL, 
defaultHaob
default XY, 
defaultHanc
default J, Zhao Q. (2008). Screening of Chinese medicinal plants for inhibition against clinical  isolates of 
defaultmethicillin
default-resistant 
defaultStaphylococcus 
defaultaureus
default (MRSA).
default  
defaultEthnopharmacology
default.  120, (2): 287–290.
default  
defaultZuo
default GY, Zhang XY, Yang CX, Han J, Wang GC, 
defaultBian
default ZQ. (2012a). Evaluation of traditional Chinese medicinal plants for anti-MRSA Activity with reference to the treatment record of infectious diseases.  
defaultMolecules
default.  17: 2955-2967.
default 
defaultHu
default, J., Zhang, J., Zhao, W., Zhang, Y.  Shang, H. Cochrane systematic reviews of Chinese herbal medicines: an overview. 
defaultPloS
default one
default 6, e28696 (2011).
default 
defaultHubbert
default M, 
defaultSievers
default H, 
defaultLehnfeld
default R, 
defaultKehrl
default W. Efficacy and tolerability of a spray with 
defaultSalvia 
defaultofficinalis
default in the treatment of acute 
defaultpharyngitis
default - a randomised, double-blind, placebo-controlled study with adaptive design and interim analysis..
defaultEur
default J Med Res
default. 2006 Jan 31;11(1):20-6.
default 
defaultSchapowal
default A, Berger D, Klein P, 
defaultSuter
default A. Echinacea/sage or 
defaultchlorhexidine
default/
defaultlidocaine
default for treating acute sore throats: a randomized double-blind trial. 
defaultEur
default J Med Res
default. 2009 Sep 1;14(9):406-12.
default Yang ZC, Wang BC, Yang XS, Wang Q, Ran L. 
defaultThe synergistic activity of antibiotics combined with eight traditional Chinese medicines against two different strains of 
defaultStaphylococcus 
defaultaureus
default.
default 
defaultColloids Surf B 
defaultBiointerfaces
default. 2005 Mar 25;41(2-3):79-81
default.
default Sharma SM, Anderson M, 
defaultSchoop
default SR, Hudson JB. 
defaultBactericidal and anti-inflammatory properties of a standardized Echinacea extract (
defaultEchinaforce
default): dual actions against respiratory bacteria.
default 
defaultPhytomedicine
default.
default 2010 Jul;17(8-9):563-8..
default 
defaultHubbert
default M, 
defaultSievers
default H, 
defaultLehnfeld
default R, 
defaultKehrl
default W. Efficacy and tolerability of a spray with 
defaultSalvia 
defaultofficinalis
default in the treatment of acute 
defaultpharyngitis
default - a randomised, double-blind, placebo-controlled study with adaptive design and interim analysis. 
defaultEur
default J Med Res
default. 2006 Jan 31;11(1):20-6.
default Watkins F, 
defaultPendry
default B, Sanchez-Medina A, Corcoran O. 
defaultAntimicrobial assays of three native British plants used in Anglo-Saxon medicine for wound healing formulations in 10th century England.
default 
defaultJ 
defaultEthnopharmacol
default. 2012 Nov 21;144(2):408-15..
defaultChan YS, Cheng LN, Wu JH, Chan E, Kwan YW, Lee SM, Leung GP, Yu PH, Chan SW. 
defaultA review of the pharmacological effects of 
defaultArctium
default 
defaultlappa
default (burdock).
default 
defaultInflammopharmacology
default. 2011 Oct;19(5):245-54. .
default 
defaultYarnell
default E.  
defaultBotanical medicines for the urinary tract.
default 
defaultWorld J Urol.
default 2002 Nov;20(5):285-93. 
default European Medicines Agency (2012). Assessment report on 
defaultArctostaphylos
default 
defaultuva-ursi
default (L.) 
defaultSpreng
default., folium, 24 January 2012 EMA/HMPC/573462/2009 Rev.1 (HMPC)
default.
default Larsson, B., 
defaultJonasson
default, A., &amp; 
defaultFianu
default, S. (1993). Prophylactic effect of UVA-E in women with recurrent cystitis: A preliminary report. 
defaultCurrent Therapeutic Research
default, 53(4), 441-443.
default 
defaultSiegers
default, C., 
defaultBodinet
default, C., Ali, S., &amp; 
defaultSiegers
default, C. (2003). Bacterial 
defaultdeconjugation
default of 
defaultarbutin
default by 
defaultEscherichia coli
default. 
defaultPhytomedicine
default, 10(4), 58-60.
default 
defaultRafsanjany
default N, 
defaultLechtenberg
default M, 
defaultPetereit
default F, 
defaultHensel
default A. 
defaultAntiadhesion
default as a functional concept for protection against 
defaulturopathogenic
default 
defaultEscherichia coli:
default in vitro studies with traditionally used plants with 
defaultantiadhesive
default activity against 
defaulturopathognic
default 
defaultEscherichia coli.
default 
defaultJ 
defaultEthnopharmacol
default. 2013 Jan 30;145(2):591-7. 
default 
defaultUlbricht C
default, Abrams TR, Conquer J, Costa D, Serrano JM, 
defaultIovin
default R, Isaac R, Nguyen Y, 
defaultRusie
default E, Tran D, 
defaultWeissner
default W, Windsor RC (2010).  An evidence-based systematic review of 
defaultumckaloabo
default (
defaultPelargonium 
defaultsidoides
default) by the Natural Standard Research Collaboration
default.   Journal of Dietary Supplements
default ;7(3):283-302.
default 
defaultFintelmann
default V, Albrecht U, Schmitz G, 
defaultSchnitker
default J.  
defaultEfficacy and safety of a combination herbal medicinal product containing nasturtium (
defaultTropaeoli
default 
defaultmajoris
default 
defaultherba
default)  and Horseradish (
defaultArmoracia
default 
defaultrusticana
default)
defaultfor the prophylactic treatment of patients with respiratory tract diseases: a 
defaultrandomised
default, prospective, double-blind, placebo-controlled phase III trial.  
defaultCurrent Medical Research Opinion
default; 28(11):1799-807 (2012).
default Ibid.
default 
defaultPuram
default S,  
defaultSuh
default, 
defaultSeung
default HC, Kim U, et al., “Effect of 
defaultGutGard
default in the Management of 
defaultHelicobacter pylori
default: A Randomized Double Blind Placebo Controlled Study,” E
defaultvidence-Based Complementary and Alternative Medicine,
default vol. 2013, Article ID 263805, 8 pages, 2013.oi:10.1155/2013/263805.
default Ibid.
default 
defaultAlbrecht U
default, 
defaultGoos
default KH
default, 
defaultSchneider B
default. (2007).  A 
defaultrandomised
default, double-blind, placebo-controlled trial of a herbal medicinal product containing 
defaultTropaeoli
default 
defaultmajoris
default 
defaultherba
default (Nasturtium) and 
defaultArmoraciae
default 
defaultrusticanae
default radix (Horseradish) for the prophylactic treatment of patients with chronically recurrent lower urinary tract infections.  
defaultCurrent Medical Research Opinion;
default23(10):2415-22.
default Ibid.
default Huang MJ. A randomised control trial of a complex Chinese herbal medicine (San Ling 
defaultJie
default Du Tang) in the treatment of women with recurrent lower urinary tract infections (RUTIs
default).  Hubei Journal of Traditional Chinese Medicine
default;29:38-9 (2007).
default Ibid.
default Huang Y, Wu T, 
defaultZeng
default , Li S.  A Cochrane systematic review of Chinese herbs for sore throat
default, 
defaultCochrane Database Systematic Review
default. 14;3:CD004877 (2012). 
default Ibid.
default Salem EM, 
defaultYar
default T, 
defaultBamosa
default AO, Al-
defaultQuorain
default A, 
defaultYasawy
default MI, 
defaultAlsulaiman
default RM, 
defaultRandhawa
default MA.(2010). Comparative study of 
defaultNigella
default 
defaultsativa
default and triple therapy in eradication of 
defaultHelicobacter pylori
default in patients with non-ulcer dyspepsia.  
defaultSaudi Journal of Gastroenterology
default. 16(3):207-14.
default Ibid.
default